ArticleProcedia computer science2022
On the accuracy of Covid-19 forecasting methods in Russia for two years.
Article in Procedia computer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The effectiveness of predicting the dynamics of the coronavirus pandemic for Russia as a whole and for Moscow is studied for a two-year period beginning March 2020. The comparison includes well-proven population models and statistic methods along with a new data-driven model based on the LSTM neural network. The latter model is trained on a set of Russian regions simultaneously, and predicts the total number of cases on the 14-day forecast horizon. Prediction accuracy is estimated by the mean absolute percent error (MAPE). The results show that all the considered models, both simple and more complex, have similar efficiency. The lowest error achieved is 18% MAPE for Moscow and 8% MAPE for Russia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.